E909:XETRA:XETRA-Lyxor 1 DAX 50 ESG (DR) UCITS ETF I (EUR)

ETF | Others |

Last Closing

USD 44.21

Change

+0.15 (+0.34)%

Market Cap

USD 0.30B

Volume

7.58K

Analyst Target

N/A
Analyst Rating

Sell

ducovest Verdict
Created with Highstock 5.0.6

Very Bearish

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
E909:XETRA
Relative Returns (From:    To: 2025-01-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CA1:XETRA Circus SE

+0.60 (+3.17%)

USD 0.51B
7V0:XETRA Darwin AG

+0.20 (+0.74%)

USD 0.08B
TY3S:XETRA WisdomTree US Treasuries 10Y 3..

-2.47 (-2.30%)

N/A
AXTZ:XETRA 21Shares Tezos staking ETP

+0.12 (+2.42%)

N/A
42FB:XETRA AI/ML Innovations Inc.

+0.01 (+20.00%)

N/A
ABCH:XETRA 21Shares Bitcoin Cash ETP

+0.45 (+3.42%)

N/A
8PSB:XETRA Invesco Physical Markets PLC O

+0.03 (+0.10%)

N/A
BTIC:XETRA Invesco Physical Bitcoin ETN E..

+0.45 (+0.50%)

N/A
2BTD:XETRA 2BTD

+0.40 (+1.25%)

N/A
8PSC:XETRA Source Physical Palladium P

-1.34 (-1.47%)

N/A

ETFs Containing E909:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.26% 90% A- 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.26% 90% A- 85% B
Trailing 12 Months  
Capital Gain 18.76% 71% C- 71% C-
Dividend Return 2.96% 66% D+ 57% F
Total Return 21.72% 76% C+ 75% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.77% 48% F 48% F
Dividend Return 6.67% 49% F 49% F
Total Return 0.90% 66% D+ 45% F
Risk Return Profile  
Volatility (Standard Deviation) 13.95% 44% F 54% F
Risk Adjusted Return 47.84% 43% F 48% F
Market Capitalization 0.30B 54% F 48% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.